Results 1 to 10 of about 187,468 (310)

Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data

open access: yesBMC Gastroenterology, 2023
Background No randomized controlled trials have been completed to see whether statin can decrease hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) patients.
Dong Hyun Sinn   +6 more
doaj   +1 more source

The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes

open access: yesDose-Response, 2019
Purpose: To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. Method: Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were ...
Shang-Yi Li   +4 more
doaj   +1 more source

Combination of Statin and Ezetimibe versus Statin Monotherapy on Cardiovascular Disease and Type 2 Diabetes Incidence among Adults with Impaired Fasting Glucose: a Propensity-Matched Nationwide Cohort Study

open access: yesJournal of Lipid and Atherosclerosis, 2021
Objective We investigated the effects of statin-ezetimibe combination therapy compared with statin-only treatment on the hazard of incident type 2 diabetes (T2D), myocardial infarction (MI), and stroke among adults with impaired fasting glucose (IFG) in
You-Bin Lee   +8 more
doaj   +1 more source

Statin use and cognitive function: population-based observational study with long-term follow-up.

open access: yesPLoS ONE, 2014
We aimed to evaluate the association between statin use and cognitive function. Cognitive function was measured with the Ruff Figural Fluency Test (RFFT; worst score, 0; best score, 175 points) and the Visual Association Test (VAT; low performance, 0-10;
Hanneke Joosten   +6 more
doaj   +1 more source

Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort

open access: yesCardiovascular Diabetology, 2022
Background Prior studies of the glycemic effect of statins have been inconsistent. Also, most studies have only considered a short duration of statin use; the effect of long-term statin use on fasting glucose (FG) has not been well examined.
Tanushree Haldar   +7 more
doaj   +1 more source

UJI KLINIS TERBUKA EFEK TERAPI STATIN (SIMVASTATIN) TERHADAP KADAR HIGH SENSITIVITY C-REACTIVE PROTEIN (hs-CRP) PADA PENDERITA DIABETES TIPE 2

open access: yesSaintika Medika, 2012
Latar Belakang. Diabetes mellitus (DM) mempunyai resiko kematian karena penyakit kardiovaskular dua sampai enam kali dibanding pasien tanpa DM. diketahui bahwa inflamasi berperan dalam pathogenesis aterosklerosis.
Isbandiyah .
doaj   +1 more source

Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study.

open access: yesPLoS ONE, 2023
BackgroundAlthough statins are an effective strategy for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD) in the general population, the benefits for dialysis patients are controversial.
Myunhee Lee   +5 more
doaj   +1 more source

Statin Therapy and Symptom Burden in Patients With Fibromyalgia: A Prospective Questionnaire Study

open access: yesMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2021
Objective: To evaluate the association between statin use and symptom severity, tender point count, fatigue, cognition, mood, and sleep issues in patients with fibromyalgia (FM).
Ryan S. D’Souza, MD   +2 more
doaj   +1 more source

Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature

open access: yesPharmacy, 2022
Statins are lipid-lowing medications shown to reduce cardiovascular events and are recommended for specific patient populations at elevated risk of atherosclerotic cardiovascular disease (ASCVD).
Mary Elkomos   +2 more
doaj   +1 more source

2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance

open access: yesJournal of the Formosan Medical Association, 2019
Statin reduces low-density lipoprotein cholesterol and improves clinical outcomes in high risk patients. In general, statin is a safe and well-tolerated medication.
Shih-Chieh Chien   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy